Resolve
Confirm the legal entity and jurisdiction before retrieving ownership.
Start with the exact legal entity. Follow supported ownership to the people behind it. Keep registry facts, public evidence, calculations and unresolved gaps visibly separate.
Each solution uses the same company and ownership foundation, but the workflow, output and evidence boundary change with the buyer's decision.
Give onboarding teams one evidence file for the legal entity, direct shareholders, ultimate owners and unresolved gaps—without turning every corporate customer into a manual research case.
Identify people reached through direct and indirect ownership, keep control indicators separate from equity, and show exactly how each conclusion was produced for review and audit.
Verify the contracting entity, understand its ownership and group perimeter, and give procurement and risk teams one sourced record they can review together.
Move from a target company to shareholders, intermediate entities, ultimate owners and supported corporate connections—while preserving the source and match rationale behind every line of inquiry.
See who owns the target, which entities belong in the group, where minority interests sit and what the available ownership history can—and cannot—establish.
Resolve the legal entity, trace ownership, cite the underlying records and preserve the limits of the evidence in a report another professional can reproduce.
Match submitted business details to the correct company, understand who is behind it and return evidence states your onboarding and trust teams can use at scale.
Return resolved entities, ownership paths, source states and explicit gaps through API or MCP—so an agent can explain what is known instead of improvising what is missing.
Zavia does not turn a missing shareholder, conflicting percentage or possible identity match into a confident owner. The gap remains part of the result.
See the evidence modelBring a company with a difficult ownership chain. Review the entity match, sources, calculation and evidence gaps before discussing rollout.